Ultrasound opens brain barrier to deliver drug in Parkinson's trial
NCT ID NCT04370665
First seen Jan 26, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This small pilot study tested whether a focused ultrasound technique could safely open the blood-brain barrier in 4 Parkinson's patients to deliver the drug Cerezyme. The main goal was to see if the barrier opened on MRI scans and to check for side effects. The study did not aim to treat Parkinson's, but to gather knowledge about this delivery method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
Conditions
Explore the condition pages connected to this study.